Umberto Pensato on Reperfusion Outcomes in Stroke
Umberto Pensato, Assistant Professor of Neurology at the Humanitas University, Research Collaborator at the University of Calgary, shared on LinkedIn:
”In this opinion paper published in Stroke, we argue against reperfusion in every ischemic stroke patient.
Reperfusion can be beneficial, futile, or harmful depending on the extension and (most importantly) severity of the ischemic core.
Moreover, both relative and absolute treatment effects should be considered for treatment decision-making.
Notably, this opinion paper was born from a vivid discussion about a single patient with my Canadian mentors: Michael Hill, Bijoy Menon, Johanna Ospel, Andrew Demchuk; Humanitas University; University of Calgary; American Heart Association”
Read the full article in Stroke.
Article: Futile and Harmful Reperfusion and the Balance Between Treatment Effect and Overall Outcomes in Stroke
Authors: Umberto Pensato, Michael D. Hill, Bijoy K. Menon, Andrew M. Demchuk, Johanna M. Ospel

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jun 26, 2026, 10:59Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
-
Jun 26, 2026, 10:52Chinua Onyebuchi: The Future of Stroke Care in Africa Lies in Strong Health Systems
-
Jun 26, 2026, 10:35Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region
-
Jun 26, 2026, 10:11Kayla Kilani: First-Ever CT Perfusion Scan Performed Inside a Mobile Stroke Unit
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
-
Jun 26, 2026, 07:10Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
-
Jun 26, 2026, 06:01Nicolas Hubacz: A Sharper Look at the Brain’s Vascular Landscape
-
Jun 26, 2026, 05:57Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk